Aneta Szudy-Szczyrek

19PUBLICATIONS
24CO-AUTHORS
Medical mycologyPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Cancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Mar 28, 2024
In Vitro Low-Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S-Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Account the GSTT1 and GSTM1 Gene Variants.

Szymon Zmorzynski, Sylwia Popek-Marciniec, Beata Biernacka

|Nov 25, 2023
The Clinical Relevance of Selected Cytokines in Newly Diagnosed Multiple Myeloma Patients.

Michał Mielnik, Aneta Szudy-Szczyrek, Iwona Homa-Mlak

|Oct 14, 2023
Association of Chromosome 17 Aneuploidy, TP53 Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment.

Sylwia Popek-Marciniec, Wojciech Styk, Magdalena Wojcierowska-Litwin

|Jun 28, 2023
Pleural Neoplasms-What Could MRI Change?

Michał Szczyrek, Paulina Bitkowska, Marta Jutrzenka

|Apr 13, 2023
The TT Genotype of the KIAA1524 rs2278911 Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma.

Aneta Szudy-Szczyrek, Radosław Mlak, Marcin Mazurek

|Mar 29, 2023
The Relationship of CCL5 and CCR1 Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma.

Sylwia Popek-Marciniec, Wojciech Styk, Magdalena Wojcierowska-Litwin

Pageof 4

Frequent Collaborators

5 joint publications

Wojciech Styk

4 joint publications

Sylwia Popek-Marciniec

4 joint publications

Radosław Mlak

3 joint publications

Sylwia Chocholska